These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 14719491)

  • 1. Canada will have a national HIV vaccine plan.
    Garmaise D
    Can HIV AIDS Policy Law Rev; 2002 Dec; 7(2-3):29. PubMed ID: 14719491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Global HIV/AIDS Vaccine Enterprise: scientific strategic plan.
    Global HIV/AIDS Vaccine Enterprise
    PLoS Med; 2005 Feb; 2(2):e25. PubMed ID: 15740411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Convergent ethical issues in HIV/AIDS, tuberculosis and malaria vaccine trials in Africa: Report from the WHO/UNAIDS African AIDS Vaccine Programme's Ethics, Law and Human Rights Collaborating Centre consultation, 10-11 February 2009, Durban, South Africa.
    Mamotte N; Wassenaar D; Koen J; Essack Z
    BMC Med Ethics; 2010 Mar; 11():3. PubMed ID: 20211030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Grappling with global concerns in the search for an HIV vaccine.
    Grady C
    J Assoc Nurses AIDS Care; 1999; 10(1):17-20. PubMed ID: 9934666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [AIDS vaccines: promises and reality].
    Goudsmit J
    Ned Tijdschr Geneeskd; 2001 Jun; 145(26):1241-5. PubMed ID: 11455689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expanding research capacity and accelerating AIDS vaccine development in Asia.
    Excler JL; Pitisuttithum P; Rerks-Ngarm S; Shao Y; Zhang L; Tamashiro H; Osmanov S;
    Southeast Asian J Trop Med Public Health; 2008 Jul; 39(4):766-84. PubMed ID: 19058617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. G-8 endorses new global HIV vaccine enterprise.
    Bull World Health Organ; 2004 Jul; 82(7):557. PubMed ID: 15500292
    [No Abstract]   [Full Text] [Related]  

  • 8. Defining the objectives of the AIDS vaccine for Asia network: report of the WHO-UNAIDS/Global HIV vaccine enterprise regional consultation on expanding AIDS vaccine research and development capacity in Asia.
    Rerks-Ngarm S; Pitisuttithum P; Ganguly N; Zhang L; Tamashiro H; Cooper DA; Vun MC; Bela B; Ditangco R; Van Kinh N; Bernstein A; Osmanov S; Mathieson B; Kent SJ; Shao Y
    Curr Opin HIV AIDS; 2010 Sep; 5(5):435-52. PubMed ID: 20978386
    [No Abstract]   [Full Text] [Related]  

  • 9. An HIV/AIDS vaccine: where do we go from here?
    Bernstein A
    Trends Microbiol; 2008 Dec; 16(12):553-4. PubMed ID: 18964019
    [No Abstract]   [Full Text] [Related]  

  • 10. The International AIDS Vaccine Initiative.
    Berkley S
    J Int Assoc Physicians AIDS Care; 1997 Nov; 3(11):30-4. PubMed ID: 11364811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of an AIDS vaccine: perspective from the South African AIDS Vaccine Initiative.
    Tucker TJ; Mazithulela G
    BMJ; 2004 Aug; 329(7463):454-6. PubMed ID: 15321907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparations for AIDS vaccine evaluations. AIDS International Training and Research Program.
    Bridbord K
    AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S227-9. PubMed ID: 7865307
    [No Abstract]   [Full Text] [Related]  

  • 13. Eureka! Success of combo HIV vaccine raises hopes, should revitalize research. An HIV vaccine shows surprising efficacy in human trials.
    AIDS Alert; 2009 Nov; 24(11):121-3. PubMed ID: 19960605
    [No Abstract]   [Full Text] [Related]  

  • 14. Partnership for HIV vaccine research in Africa.
    Sanders E
    Ethiop Med J; 2003 Jun; 41 Suppl 1():5-7. PubMed ID: 15227875
    [No Abstract]   [Full Text] [Related]  

  • 15. Executive summary and recommendations from the WHO/UNAIDS/IAVI expert group consultation on 'Phase IIB-TOC trials as a novel strategy for evaluation of preventive HIV vaccines', 31 January-2 February 2006, IAVI, New York, USA.
    WHO/UNAIDS/IAVI International Expert Group
    AIDS; 2007 Feb; 21(4):539-46. PubMed ID: 17301582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The future of HIV vaccine research and the role of the Global HIV Vaccine Enterprise.
    Voronin Y; Manrique A; Bernstein A
    Curr Opin HIV AIDS; 2010 Sep; 5(5):414-20. PubMed ID: 20978383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The challenges of an HIV vaccine enterprise.
    Wolf H
    Science; 2004 Feb; 303(5662):1294-7; author reply 1294-7. PubMed ID: 14991961
    [No Abstract]   [Full Text] [Related]  

  • 18. US and Thai Governments defend HIV/AIDS vaccine trial in Thailand.
    Agnew B
    Bull World Health Organ; 2004 Mar; 82(3):231. PubMed ID: 15112014
    [No Abstract]   [Full Text] [Related]  

  • 19. Global HIV vaccines: economic considerations.
    Petricciani JC
    AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S293-4. PubMed ID: 7865321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The global HIV vaccine enterprise.
    Esparza J
    Int Microbiol; 2005 Jun; 8(2):93-101. PubMed ID: 16052457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.